gja1 Antibody

Shipped with Ice Packs
In Stock

Description

Introduction to GJA1 Antibody

GJA1 antibodies are immunological tools targeting Connexin 43 (Cx43), a 43 kDa gap junction protein encoded by the GJA1 gene. These antibodies enable the study of Cx43's role in cell-cell communication, tissue homeostasis, and diseases such as cardiac arrhythmias, hearing loss, and ciliopathies . GJA1 antibodies are widely used in techniques including Western blot (WB), immunohistochemistry (IHC), and immunofluorescence (IF) .

Key Features of GJA1:

  • Molecular Weight: 43 kDa (predicted and observed)

  • UniProt ID: P17302

  • Domains: Four transmembrane domains (TM1–4), intracellular N- and C-termini, and extracellular loops .

Post-Translational Modifications (PTMs):

SiteModification TypeEnzyme/SourceBiological Relevance
S255PhosphorylationMAPK1, CDK1Regulates channel gating
S368PhosphorylationPKC isoformsModulates gap junction assembly
Y247PhosphorylationSRC kinaseLinked to cardiac remodeling
K9UbiquitinationUniprotAffects protein turnover

Cardiac Research

  • Intercalated Disc Localization: GJA1 antibodies (e.g., Abcam ab235585) detect Cx43 at cardiac intercalated discs, critical for electrical coupling in cardiomyocytes .

  • Therapeutic Insights: AAV9-mediated GJA1-20k overexpression increases Cx43 plaque size, improving cardiac conduction .

Ciliogenesis Studies

  • Ciliary Defects: Dominant-negative GJA1 mutants (e.g., Δ234–243) disrupt Rab11 trafficking, leading to shortened ciliary axonemes in Xenopus and human RPE1 cells .

  • Mechanism: GJA1 interacts with Rab11a to regulate vesicle trafficking to basal bodies, as shown by co-immunoprecipitation and siRNA knockdown .

Technical Validation Data

Antibody CloneApplicationKey Validation
Affinity AF0137WB, IHC, IFReacts with human, mouse, rat; predicts cross-reactivity in pig, zebrafish
Abcam ab11370WB, IHCValidated in knockout cell lines (U-87 MG, HEK-293)
Boster PA1026WB, IFDetects 43 kDa band in human placenta and rodent tissues

Cardiac Muscle Studies

  • IHC Staining: Robust Cx43 signal at intercalated discs in human, mouse, and rat cardiac tissues using ab235585 at 1:500–1:1000 dilutions .

  • Pathological Insights: Reduced Cx43 expression correlates with arrhythmias in ischemic heart disease models .

Ciliary Trafficking Mechanisms

  • Rab11 Interaction: IP-MS data confirm GJA1 binds Rab11a, essential for ciliary vesicle delivery .

  • Phenotypic Rescue: siRNA-mediated GJA1 depletion in RPE1 cells reduces cilia length by 60%, reversible via cDNA complementation .

Validation and Quality Control

  • Western Blot: All commercial antibodies show a single 43 kDa band in cardiac/brain lysates .

  • Knockout Validation: ab11370 exhibits no signal in GJA1-knockout HEK-293 cells, confirming specificity .

  • Cross-Reactivity: AF0137 predicts reactivity with pig, bovine, and zebrafish Cx43 via sequence alignment .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
gja1; cx43; shf; sof; Gap junction alpha-1 protein; Connexin-43; Cx43; Short fin protein
Target Names
Uniprot No.

Target Background

Function
Gap junctions, crucial for intercellular communication, are comprised of clusters of connexons, transmembrane channels enabling the diffusion of low molecular weight materials between adjacent cells. Connexin43 (Cx43) plays a vital role in gap junction communication within the ventricles and contributes to the regulation of fin bone size and growth.
Gene References Into Functions

Gene References and Functions:

  1. Connexin43 (Cx43) has been identified as the gene responsible for the "short-of-fin" (sof) phenotype, characterized by shortened fin ray segments with normal vertebrae. PMID: 27129238
  2. The gene serpinh1b, encoding the protein Hsp47, a molecular chaperone involved in the proper folding of procollagen molecules, functions downstream of cx43. PMID: 26103547
  3. Hapln1a-ECM stabilizes the secreted growth factor Semaphorin3d (Sema3d), which has been independently shown to mediate Cx43-dependent phenotypes during regeneration. PMID: 26828861
  4. Hapln1a plays a critical role in connexin43-dependent growth and patterning in the regenerating fin skeleton. PMID: 24533114
  5. Increased expression of Cx43 has been observed in Dupuytren's disease. PMID: 24359029
  6. Sema3d functions in a common molecular pathway with Cx43, impacting cell proliferation and joint formation. PMID: 22542598
  7. Fibroblasts cultured from patients with ossification of the posterior longitudinal ligament (OPLL) exhibit osteogenic characteristics, with Cx43 playing a significant role. PMID: 21311398
  8. Cardiomyogenesis is influenced by stimuli from the cellular microenvironment, where connexin43 plays a crucial role. PMID: 21931658
  9. Studies indicate a cross-talk between IGF-1R and AT-1R in AT-II and IGF-1-induced Cx43 expression in SV SMCs, involving Erk 1/2 and downstream activation of the AP-1 transcription factor. PMID: 20731749
  10. Alterations in astrocyte connexins may contribute to the suicide process, further implicating astrocytes in psychopathology. PMID: 21571253
  11. Gap junctional intercellular communication in human bladder smooth muscle cells and suburothelial myofibroblasts relies primarily on Cx43 rather than Cx45. PMID: 21674053
  12. Connexin43 (Cx43) is essential for late primitive and definitive hematopoiesis in zebrafish. PMID: 20020200
  13. Cx43 is crucial for the reassembly of tight junctions at the blood-testis barrier during its cyclic restructuring throughout the seminiferous epithelial cycle of spermatogenesis. PMID: 20921394
  14. Neonatal murine atrial myocytes exhibit similar abundances of Cx40 and Cx43 proteins, while ventricular myocytes contain at least 20 times more Cx43 than Cx40. PMID: 19486903
  15. In studied colon tumors, there is either a lack of membranous distribution of connexins or a shift from moderately membranous immunoreactivity to predominantly cytoplasmic accumulation of CX32 and CX43. PMID: 20133984
  16. Cx48.5, Cx44.1, and Cx43 play roles in lens development. PMID: 14648847
  17. The fin length mutant "short fin" (sof), causing defects in the length of bony fin ray segments, is caused by mutations in the connexin43 (cx43) gene. PMID: 15649473
  18. Molecular cloning suggests that Cx43alpha1 gap junctions likely have conserved roles in vertebrate embryonic development. PMID: 15895415
  19. Measurable differences in Cx43 function may correlate with the severity of defects in bone length. PMID: 17599838
  20. Connexin43 (GJA1) is required in the population of dividing cells during fin regeneration. PMID: 18406403
  21. Results reveal a correlation between the level of Cx43 expression in the fin ray mesenchyme and the location of joints in developing zebrafish. PMID: 19150347
  22. The role of Cx43.4 appears to be conserved, given that its ortholog, human Cx45, is able to functionally compensate for zebrafish Cx43.4 during left-right patterning. PMID: 19799895
Database Links

KEGG: dre:30236

STRING: 7955.ENSDARP00000061260

UniGene: Dr.75809

Protein Families
Connexin family, Alpha-type (group II) subfamily
Subcellular Location
Cell membrane; Multi-pass membrane protein. Cell junction, gap junction.
Tissue Specificity
Expressed in adult ovary, heart, lens and liver. In growing caudal fins, expressed in cells flanking the germinal region of newly growing segments and in osteoblasts at segment boundaries.

Q&A

What is GJA1/Connexin 43 and why is it important in research?

GJA1 (Gap Junction Protein Alpha 1), also known as Connexin 43 (Cx43), is a 43 kDa protein consisting of 382 amino acids that forms gap junction channels between adjacent cells. It is the most common connexin in cardiac muscle cells and is also found in hepatocytes, astrocytes, and ovary granulosa cells . GJA1 is critical for intercellular communication, allowing direct transfer of ions and small molecules (less than 1 kDa) between cells . This protein plays essential roles in muscle contraction, embryonic development, inflammation, and spermatogenesis, making it a significant target in multiple research fields including cardiology, neuroscience, and developmental biology .

What is the basic structure of GJA1 and how does it function in gap junctions?

GJA1 has a complex structure consisting of:

  • Four transmembrane domains

  • A long C-terminal tail (151 amino acids)

  • A shorter N-terminal domain (12 amino acids)

  • Two extracellular loops

The C-terminal tail is particularly important as it contains multiple post-translational modification sites and binding domains for interaction with transcription factors, cytoskeletal elements, and other regulatory proteins . Six connexin proteins form a hexameric structure called a connexon (or hemi-channel). When connexons from adjacent cells align, they create a functional gap junction channel that allows for the exchange of small molecules between cells .

What is the typical half-life of GJA1 and how does this affect experimental design?

GJA1 has a remarkably short half-life of only 2-4 hours, which suggests rapid protein turnover under normal physiological conditions . This short half-life has significant implications for experimental design. Researchers should consider rapid sample processing and preservation techniques to avoid protein degradation. Additionally, time-course experiments studying GJA1 expression or localization should account for this rapid turnover rate when designing sampling intervals and interpreting results.

What criteria should be considered when selecting a GJA1 antibody for specific applications?

When selecting a GJA1 antibody, researchers should consider:

ConsiderationImportanceExamples
Epitope locationDifferent domains may be accessible in different applicationsC-terminal antibodies for WB; extracellular loop antibodies for detecting intact gap junctions
Host speciesAvoid cross-reactivity with secondary antibodiesConsider rabbit polyclonal for multi-species detection
Validated applicationsEnsure antibody works in your applicationWB, IHC, ICC, IF, ELISA as indicated in product specifications
Phospho-specificityIf studying phosphorylation statesPhospho-Ser368 specific antibodies for studying regulatory phosphorylation
Species reactivityEnsure cross-reactivity with your model organismHuman, mouse, rat reactivity is common for most antibodies

Researchers should review published literature and antibody validation data to ensure the selected antibody has been successfully used in similar experimental contexts.

How can I verify antibody specificity for GJA1 in my experimental system?

To validate GJA1 antibody specificity:

  • Include positive controls known to express GJA1 (heart tissue, astrocytes)

  • Use negative controls with GJA1 knocked down or knocked out

  • Perform peptide competition assays to confirm epitope specificity

  • Compare multiple antibodies targeting different epitopes

  • Verify expected molecular weight (41-44 kDa) in Western blots, with potential higher molecular weight bands representing phosphorylated forms

  • Confirm expected subcellular localization at cell-cell junctions by immunofluorescence

  • For phospho-specific antibodies, treat samples with phosphatases to demonstrate specificity

What are the optimal sample preparation methods for preserving GJA1 integrity in different applications?

For Western Blotting:

  • Use ice-cold lysis buffers containing phosphatase inhibitors to preserve phosphorylation status

  • Include protease inhibitors to prevent degradation of the short-lived GJA1 protein

  • Process samples quickly and maintain cold temperatures throughout preparation

  • Consider using SDS sample buffer with higher concentrations of reducing agents to ensure complete denaturation of gap junction complexes

For Immunohistochemistry/Immunofluorescence:

  • Use paraformaldehyde fixation (4%) for optimal epitope preservation

  • For phospho-specific detection, use rapid fixation protocols to maintain phosphorylation status

  • Consider antigen retrieval methods to expose masked epitopes in formalin-fixed tissues

  • When detecting native gap junctions, gentle permeabilization methods are recommended to preserve membrane structure

For Flow Cytometry:

  • Use gentle cell dissociation methods to maintain membrane integrity

  • Consider fixation with 1-2% paraformaldehyde for intracellular epitope detection

  • For T regulatory cells specifically, optimize permeabilization conditions as demonstrated in R&D Systems protocols

How should I design experiments to study GJA1 phosphorylation and its functional significance?

Phosphorylation of GJA1, particularly at Serine 368, is a key regulatory mechanism affecting gap junction communication . To study GJA1 phosphorylation:

  • Use phospho-specific antibodies targeting key sites like Ser368

  • Include both phospho-specific and total GJA1 antibodies in parallel experiments to determine phosphorylation relative to total protein levels

  • Design experiments with appropriate stimuli known to induce phosphorylation (e.g., PKC activators)

  • Include phosphatase inhibitors in all buffers during sample preparation

  • Consider using phosphatase treatments as negative controls

  • For functional studies, correlate phosphorylation status with gap junction communication using dye transfer assays or electrophysiological measurements

  • Design time-course experiments to capture the dynamic nature of phosphorylation events

What controls are essential when using GJA1 antibodies in different applications?

ApplicationEssential Controls
Western Blot- Positive control (heart tissue extract)
- Loading control (housekeeping protein)
- Molecular weight marker to confirm 43 kDa band
- Secondary antibody-only control
Immunohistochemistry- Positive tissue control (heart, brain)
- Negative tissue control (tissue with low GJA1 expression)
- Isotype control antibody
- No primary antibody control
Flow Cytometry- Isotype control antibody as shown in R&D Systems data
- Unstained cells
- Secondary antibody-only control
- Known positive and negative cell populations
Immunofluorescence- Membrane markers to confirm junctional localization
- DAPI nuclear counterstain
- Secondary antibody-only control
- Blocking peptide competition control

How can I differentiate between membrane-localized and cytoplasmic GJA1 in experimental analyses?

Distinguishing between different subcellular pools of GJA1 is crucial for understanding its trafficking and function:

  • Use subcellular fractionation techniques to physically separate membrane and cytoplasmic fractions before Western blotting

  • In immunofluorescence studies, employ co-staining with plasma membrane markers (e.g., Na⁺/K⁺-ATPase) or organelle markers (e.g., Golgi, ER)

  • Utilize super-resolution microscopy techniques to precisely localize GJA1 at gap junction plaques versus intracellular compartments

  • Consider biotinylation assays to specifically label cell surface GJA1

  • Use Z-stack confocal imaging to differentiate between junctional plaques at cell-cell contacts and intracellular vesicular structures

  • For dynamic studies, consider using GJA1-GFP fusion constructs in live-cell imaging experiments

What are the methodological approaches for studying GJA1 trafficking and turnover?

Given the short half-life of GJA1 (2-4 hours) , studying its trafficking and turnover requires specialized approaches:

  • Pulse-chase experiments using metabolic labeling to track newly synthesized GJA1

  • Cycloheximide chase assays to monitor protein degradation rates

  • Inhibitors of different degradation pathways (proteasomal vs. lysosomal) to determine the dominant degradation mechanism

  • Brefeldin A treatment to block ER-to-Golgi transport for studying forward trafficking

  • Temperature-block experiments (e.g., 15°C block) to synchronize trafficking through the secretory pathway

  • Total Internal Reflection Fluorescence (TIRF) microscopy to visualize insertion of new channels at the plasma membrane

  • Fluorescence Recovery After Photobleaching (FRAP) to measure gap junction dynamics at cell-cell interfaces

  • Co-immunoprecipitation studies to identify trafficking partners that regulate GJA1 movement

What techniques can be used to study functional consequences of GJA1 mutations or modifications?

To assess how mutations or post-translational modifications affect GJA1 function:

  • Dye transfer assays using gap junction-permeable dyes like Lucifer Yellow or calcein to measure intercellular communication

  • Dual-patch clamp electrophysiology to directly measure gap junction conductance

  • Site-directed mutagenesis to create phospho-mimetic (S→D) or phospho-resistant (S→A) mutations at key sites like Ser368

  • CRISPR/Cas9 gene editing to introduce mutations in endogenous GJA1

  • Bioluminescence resonance energy transfer (BRET) or Förster resonance energy transfer (FRET) assays to measure protein-protein interactions affected by mutations

  • For cardiac applications, use of cardiomyocyte models to assess impact on synchronized contraction

  • In neural systems, measure calcium wave propagation to assess functional gap junction communication

Why might I observe multiple bands for GJA1 in Western blot analysis?

GJA1 frequently appears as multiple bands in Western blots due to:

  • Post-translational modifications, particularly phosphorylation at sites like Ser368

  • Proteolytic processing during sample preparation due to its short half-life

  • Different conformational states of the protein (monomers, dimers, higher-order oligomers)

  • Presence of non-phosphorylated (~41 kDa) and phosphorylated (~43-44 kDa) forms

  • Ubiquitination resulting in higher molecular weight species

To address multiple bands:

  • Include phosphatase treatment of parallel samples to identify phosphorylation-dependent bands

  • Use more stringent denaturing conditions to disrupt oligomers

  • Optimize sample preparation to minimize proteolysis with protease inhibitors

  • Compare results with phospho-specific antibodies to identify specific modified forms

How can I optimize detection of low-abundance GJA1 in non-cardiac tissues?

For detecting GJA1 in tissues with lower expression levels:

  • Increase protein loading for Western blots, but verify equal loading with appropriate controls

  • Use more sensitive detection methods such as chemiluminescent substrates with longer exposure times

  • Consider signal amplification techniques in immunohistochemistry, such as tyramide signal amplification

  • For immunofluorescence, use high-sensitivity cameras and increase exposure time

  • Optimize antibody concentration through titration experiments

  • Try alternative antibodies that may have higher affinity or recognize different epitopes

  • For Western blots, consider membrane transfer conditions optimized for transmembrane proteins

  • Employ tissue-specific positive controls to benchmark detection sensitivity

How do I interpret contradictory results between different GJA1 antibodies or detection methods?

When facing contradictory results:

  • Verify epitope locations of different antibodies – some may detect specific phosphorylated forms while others detect total protein

  • Consider accessibility of epitopes in different applications (some epitopes may be masked in native conformations)

  • Review antibody validation data for each specific application

  • Assess fixation and permeabilization effects on epitope availability, especially for membrane proteins

  • Consider that different detection methods have varying sensitivities and may reveal different aspects of GJA1 biology

  • Examine post-translational modifications that might affect antibody recognition

  • Validate findings using alternative approaches (e.g., mRNA expression, functional assays)

  • When possible, use genetic approaches (knockdown, knockout) to confirm specificity

What are the emerging roles of GJA1 beyond traditional gap junction communication?

Recent research has uncovered non-canonical functions of GJA1:

  • Regulation of gene expression through interaction with transcription factors

  • Involvement in cell growth inhibition through regulation of NOV expression and localization

  • Channel-independent roles of C-terminal fragments in cellular signaling

  • Functioning as hemichannels that release paracrine signals like ATP

  • Regulation of bladder functional capacity by enhancing intercellular electrical and chemical transmission

  • Roles in recycling potassium to the cochlear endolymph in hearing physiology

  • Direct protein-protein interactions affecting cell migration and adhesion

Understanding these non-canonical functions requires specialized experimental approaches beyond traditional gap junction communication assays.

How can I implement cutting-edge methodologies to study GJA1 dynamics in living systems?

Advanced techniques for studying GJA1 in living systems include:

  • CRISPR/Cas9 knock-in of fluorescent tags to visualize endogenous GJA1

  • Optogenetic approaches to control GJA1 channel opening

  • Super-resolution microscopy techniques (STED, PALM, STORM) to visualize gap junction plaque architecture

  • Lattice light-sheet microscopy for long-term 3D imaging with minimal phototoxicity

  • Intravital microscopy to study GJA1 dynamics in living animals

  • Genetically-encoded voltage or calcium indicators to functionally assess gap junction communication

  • Single-molecule tracking to study GJA1 movement within the membrane

  • Correlative light and electron microscopy to link functional data with ultrastructural information

These advanced techniques offer unprecedented insights into GJA1 biology but require specialized equipment and expertise.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.